Intravenous infusion of magnesium sulfate is not associated with cardiovascular, liver, kidney, and metabolic toxicity in adults
Journal Title: Journal of Clinical and Translational Research - Year 2018, Vol 4, Issue 1
Abstract
Background: Magnesium (Mg) deficiency contributes to the pathophysiology of numerous diseases. The therapeutic use of Mg has steadily increased over time. The increased in-hospital use of intravenous (IV) magnesium sulfate (MgSO4) warrants more extensive investigation regarding the safety of the therapy. The aim of this study was to determine the safety of IV MgSO4 infusion on cardiovascular, liver, kidney, and metabolic markers in adults. Methods: Twelve volunteers were randomized to one of two cross-over conditions: (a) IV infusion of MgSO4 in 5% dextrose followed by IV infusion of 5% dextrose 1 week later or (b) IV infusion of 5% dextrose followed by IV infusion of MgSO4 in 5% dextrose 1 week later. An electrocardiogram was recorded continuously during the infusions. Blood was drawn pre- and post-infusion for blood count (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides). Results: Serum Mg increased from pre- to post-infusion in the MgSO4 + 5% dextrose group (p < 0.0001). The QRS interval length increased from pre- to post-infusion in the MgSO4 + 5% dextrose group (p <0.04). Additionally, serum glucose concentration increased in the MgSO4 + 5% dextrose group (p =0.04). These significant findings were modeled with gender and age as covariates. No other significant differences were found. Conclusions: The administration of IV infusion of MgSO4 (4 g/100 mL) in 5% dextrose over a 4-hour treatment period poses no significant deleterious effects on cardiovascular, liver, kidney, or metabolic function. Relevance for patients: IV infusion of MgSO4 may be used for certain treatment indications without significant concern for systemic or organ toxicity.
Authors and Affiliations
Elisa Karhu, Steven E. Atlas1, Jinrun Gao, Syed A. Mehdi, Dominique Musselman, Sharon Goldberg,Judi M. Woolger, Raul Corredor, Muhammad H. Abbas, Leopoldo Arosemena, Simone Caccamo, Ashar Farooqi, Janet Konefal, Laura Lantigua, Vanessa Padilla, Ammar Rasul, Eduard Tiozzo, Oscar L. Higuera, Andrea Fiallo, John E. Lewis
Keywords
Related Articles
- EP ID EP678768
- DOI -
- Views 187
- Downloads 0
IL-23 and IL-17A are not involved in hepatic/ischemia reperfusion injury in mouse and man
Background: Hepatic ischemia and reperfusion (I/R) is common in liver surgery and transplantation and compromises postoperative liver function. Hepatic I/R injury is characterized by sterile inflammation that contributes...
Assessment of the Wii Basic Balance Test in measuring postural deficits post-concussion
Background and Aim: To evaluate the Wii Basic Balance Test (WBBT), as a tool for detecting postural instability in athletes with concussions. Methods: Seventy-nine healthy physically active controls (NORM) (mean age 21...
Understanding the responsiveness of nitric oxide to acute eccentric resistance exercise in elderly obese women
Background and Aim: The aim of the present study was to examine nitrite concentration responses following eccentric resistance exercise (ERE) in elderly obese women. We also investigated the existence of high (HR) and lo...
Limitations of Quantitative Blush Evaluator (QuBE) as myocardial perfusion assessment method on digital coronary angiograms
Background and Aim: Quantitative Blush Evaluator (QuBE) is a software application that allows quantifying myocardial perfusion in coronary angiograms after a percutaneous coronary intervention. QuBE has some limitations...
Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives
Mitochondria are critical cellular organelles for energy generation and are now also recognized as playing important roles in cellular signaling. Their central role in energy metabolism, as well as their high abundance i...